MDT

100.99

-0.45%↓

A

134.88

-2.69%↓

VEEV

221.76

-1.44%↓

HQY

84.14

-2.65%↓

NEOG

9.81

-1.21%↓

MDT

100.99

-0.45%↓

A

134.88

-2.69%↓

VEEV

221.76

-1.44%↓

HQY

84.14

-2.65%↓

NEOG

9.81

-1.21%↓

MDT

100.99

-0.45%↓

A

134.88

-2.69%↓

VEEV

221.76

-1.44%↓

HQY

84.14

-2.65%↓

NEOG

9.81

-1.21%↓

MDT

100.99

-0.45%↓

A

134.88

-2.69%↓

VEEV

221.76

-1.44%↓

HQY

84.14

-2.65%↓

NEOG

9.81

-1.21%↓

MDT

100.99

-0.45%↓

A

134.88

-2.69%↓

VEEV

221.76

-1.44%↓

HQY

84.14

-2.65%↓

NEOG

9.81

-1.21%↓

Search

Simulations Plus Inc

Cerrado

SectorSanidad

20.83 0.58

Resumen

Variación precio

24h

Actual

Mínimo

20.71

Máximo

20.95

Métricas clave

By Trading Economics

Ingresos

1.4M

676K

Ventas

961K

18M

P/B

Media del Sector

48.528

89.037

BPA

-0.034

Rentabilidad por dividendo

0.48

Margen de beneficios

3.67

Empleados

212

EBITDA

-3M

2.3M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

-8.83% downside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

0.48%

2.18%

Próximas Ganancias

2 abr 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

42M

410M

Apertura anterior

20.25

Cierre anterior

20.83

Noticias sobre sentimiento de mercado

By Acuity

56%

44%

287 / 352 Clasificación en Healthcare

Simulations Plus Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

25 ene 2026, 23:49 UTC

Charlas de Mercado

Oil Falls on Possible Technical Correction -- Market Talk

25 ene 2026, 23:43 UTC

Charlas de Mercado

Correction to Gold Rises Above $5000/oz Market Talk

25 ene 2026, 23:43 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

25 ene 2026, 23:43 UTC

Charlas de Mercado

Nikkei May Fall After Yen's Sharp Rebound -- Market Talk

25 ene 2026, 23:36 UTC

Charlas de Mercado

Gold Rises Above $5,000/oz for First Time Amid Geopolitical Tensions -- Market Talk

25 ene 2026, 19:30 UTC

Adquisiciones, fusiones, absorciones

Merck No Longer in Talks to Acquire Revolution Medicines, Sources Say -- WSJ

25 ene 2026, 19:30 UTC

Adquisiciones, fusiones, absorciones

Companies Had Been Discussing Roughly $30B Deal -- WSJ

25 ene 2026, 19:30 UTC

Adquisiciones, fusiones, absorciones

Merck No Longer in Talks to Buy Revolution Medicines -- WSJ

24 ene 2026, 09:20 UTC

Charlas de Mercado

Financial Services Roundup: Market Talk

24 ene 2026, 09:20 UTC

Charlas de Mercado
Ganancias

Tech, Media & Telecom Roundup: Market Talk

24 ene 2026, 09:20 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

24 ene 2026, 09:20 UTC

Charlas de Mercado

Auto & Transport Roundup: Market Talk

24 ene 2026, 06:18 UTC

Adquisiciones, fusiones, absorciones

Our Boston Scientific Pick Has Stumbled. Acquiring Penumbra Will Help the Stock. -- Barrons.com

23 ene 2026, 22:30 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

23 ene 2026, 22:30 UTC

Charlas de Mercado

Trump Seen Using Canada's EV Deal With China to Extract Concessions -- Market Talk

23 ene 2026, 22:03 UTC

Ganancias

These Stocks Are Today's Movers: Intel, AMD, Capital One, Booz Allen, BitGo, Fortinet, and More -- Barrons.com

23 ene 2026, 21:52 UTC

Ganancias
Adquisiciones, fusiones, absorciones

GE Aerospace's Earnings Worried the Market. What CEO Larry Culp Says. -- Barrons.com

23 ene 2026, 21:50 UTC

Charlas de Mercado
Ganancias

Tech, Media & Telecom Roundup: Market Talk

23 ene 2026, 21:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

23 ene 2026, 21:50 UTC

Charlas de Mercado

Financial Services Roundup: Market Talk

23 ene 2026, 21:50 UTC

Charlas de Mercado

Auto & Transport Roundup: Market Talk

23 ene 2026, 21:39 UTC

Ganancias

Intel Returns to Losses as Supply Shortages, Spending Weigh on Q4 Results and Forecast -- 5th Update

23 ene 2026, 21:15 UTC

Adquisiciones, fusiones, absorciones

Eaton Completes Acquisition Of Ultra PCS Limited, Expanding Capabilities And Solutions For Next-generation Aerospace And Defense Markets >ETN

23 ene 2026, 21:12 UTC

Ganancias

CSX Stock Rises After Earnings Miss Estimates. It's the Outlook. -- Barrons.com

23 ene 2026, 20:31 UTC

Ganancias

These Stocks Are Today's Movers: Intel, AMD, Capital One, Booz Allen, BitGo, Fortinet, and More -- Barrons.com

23 ene 2026, 20:12 UTC

Charlas de Mercado

Oil Futures Rebound on Iran, Russia-Ukraine Risk -- Market Talk

23 ene 2026, 20:07 UTC

Charlas de Mercado

U.S. Natural Gas Posts Record Weekly Gain on Winter Storm -- Market Talk

23 ene 2026, 19:36 UTC

Charlas de Mercado

Dollar Weakens Against Yen Amid Intervention Chatter -- Market Talk

23 ene 2026, 19:30 UTC

Charlas de Mercado
Ganancias

Intel's Stock Has Limited Catalysts Ahead, Analysts Say -- Market Talk

23 ene 2026, 19:18 UTC

Charlas de Mercado

Gold and Silver Step Up to More Records -- Market Talk

Comparación entre iguales

Cambio de precio

Simulations Plus Inc previsión

Precio Objetivo

By TipRanks

-8.83% descenso

Estimación a 12 Meses

Media 19 USD  -8.83%

Máximo 19 USD

Mínimo 19 USD

De acuerdo con 5 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Simulations Plus Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

5 ratings

2

Comprar

3

Mantener

0

Vender

Sentimiento

By Acuity

287 / 352 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura bajista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Simulations Plus Inc

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through Software and Services segments. It also offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. In addition, the company provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, and OBESITYsym products. Further, it offers Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions. Additionally, the company provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions; and early drug discovery services. Furthermore, it offers creative and insightful consulting services to support its quantitative systems pharmacology and other modeling systems. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.
help-icon Live chat